T-1249

Hide Archived (Historical) Articles

T-1249 Trial Suspended: Formulation Woes Blamed (December 2003)
In GMHC Treatment Issues, from Gay Men's Health Crisis
T-1249 Retains Potent Short-Term Antiviral Activity in Patients Who Have Failed a Regimen Containing T-20 (September 14, 2003)
In The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
Cool Your Jets: T-1249 Development Slows Down (January/February 2003)
In GMHC Treatment Issues, from Gay Men's Health Crisis
New Anti-HIV Therapies: Other Fusion Inhibitors (January 2003)
[Archived Article]
To read PDF, click here
From Project Inform
Genotypic Resistance to Protease and Reverse Transcriptase Inhibitors and Antiretroviral History Do Not Affect Virologic Response to T-1249 (December 17, 2001)
[Archived Article]
In 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2001), from The Body PRO
Fusion Inhibitors (September/October 1999)
[Archived Article]
T-20 (Pentafuside) and T-1249.
In GMHC Treatment Issues, from Gay Men's Health Crisis

My Health Tracker

Widgets and RSS Feeds

U.S. ASO Finder

The First Man to Be Cured of AIDS: An Update on the Amazing Story -- This Month in HIV

OIs and Co-Infections and STIs -- Oh, My!

World AIDS Day 2009: Home

HIV Antiretrovirals in Development: An Update From ICAAC 2009

This Positive Life: An Interview With Enrique Franco

More >>

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.